Literature DB >> 20004040

Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?

Kristell Bastide1, Nicolas Ugolin, Céline Levalois, Jean-François Bernaudin, Sylvie Chevillard.   

Abstract

Adenocarcinomas (AC), squamous cell carcinomas (SCC) and adenosquamous carcinomas (ASC) are three histological subtypes of non-small-cell lung carcinomas (NSCLC). ASC are morphologically mixed tumours that contain the two cell components AC and SCC. To understand if they are a "simple" mix of AC and SCC or if they present molecular specificities, as compared with the molecular characterization of both components, we performed a comparative transcriptome analysis on a series of nine ASC, five AC and five SCC induced in rats by radon exposure. We found that 72, 40 and 39 genes were differentially expressed when comparing AC_SCC, ASC_SCC and AC_ASC, respectively. Moreover, when classifying the three histological subtypes, using genes that discriminated AC and SCC, we observed that all ASC were classified as intermediate between the AC and SCC, some being closer to AC, others to SCC. These results indicated that, regarding gene expression, ASC could be considered as a mix of AC and SCC, both in various proportions. However, they also exhibit molecular specificities since we found specific genes discriminating ASC_SCC and AC_ASC. In conclusion, the ASC mixed lung tumours are more complex than simple mixes of AC and SCC components. Neuroendocrine differentiation and ERK proliferation pathways seemed preferentially deregulated in ASC compared to AC and SCC respectively, pathways that are worthy of being explored because they could partially explain the high clinical aggressiveness of ASC. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004040     DOI: 10.1016/j.lungcan.2009.11.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  16 in total

1.  Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.

Authors:  Ye Guo; Lin Jia; Guo-Guang Shao; Hong-Wei Sun; Xing-Xing Wang; Guan-Jun Wang; Ke-Wei Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

2.  Surgical specimen histology revealed inadequacy of conventional transbronchial needle aspiration sample in the diagnosis of adenosquamous lung carcinoma.

Authors:  Jing Chen; Ya-Dong Gao; Yan Cao; Jiong Yang; Guang-Wei Luo
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

3.  Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition.

Authors:  Pavel A Levin; Melissa Mayer; Sharon Hoskin; Joseph Sailors; Dwight H Oliver; David E Gerber
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

Review 4.  Involvement of regucalcin as a suppressor protein in human carcinogenesis: insight into the gene therapy.

Authors:  Masayoshi Yamaguchi
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-18       Impact factor: 4.553

5.  A transcriptome signature distinguished sporadic from postradiotherapy radiation-induced sarcomas.

Authors:  Nabila-Sandra Hadj-Hamou; Nicolas Ugolin; Catherine Ory; Nathalie Britzen-Laurent; Xavier Sastre-Garau; Sylvie Chevillard; Bernard Malfoy
Journal:  Carcinogenesis       Date:  2011-04-05       Impact factor: 4.944

6.  Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma.

Authors:  Yi-Ran Cai; Hai-Qing Zhang; Zong-DE Zhang; Jing Mu; Zi-Hui Li
Journal:  Oncol Lett       Date:  2010-12-23       Impact factor: 2.967

7.  Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors.

Authors:  Hirotake Komatsu; Shinichi Egawa; Fuyuhiko Motoi; Takanori Morikawa; Naoaki Sakata; Takeshi Naitoh; Yu Katayose; Kazuyuki Ishida; Michiaki Unno
Journal:  Surg Today       Date:  2014-06-29       Impact factor: 2.549

8.  Notch2 inhibits proliferation of chronic myeloid leukemia cells.

Authors:  Zesong Yang; Chunxiu Yang; Shunjun Zhang; Ying Li; Jianbin Chen
Journal:  Oncol Lett       Date:  2013-01-29       Impact factor: 2.967

9.  Isolation of cancer stem like cells from human adenosquamous carcinoma of the lung supports a monoclonal origin from a multipotential tissue stem cell.

Authors:  Jennie P Mather; Penelope E Roberts; Zhuangyu Pan; Francine Chen; Jeffrey Hooley; Peter Young; Xiaolin Xu; Douglas H Smith; Ann Easton; Panjing Li; Ezio Bonvini; Scott Koenig; Paul A Moore
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

10.  Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma.

Authors:  Qiongjie Zhi; Yuqian Wang; Xinyue Wang; Dongsheng Yue; Kai Li; Richeng Jiang
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.